by Ed Hinerman | May 19, 2020 | Covid-19, life insurance
The Good And Bad News In Covid 19 Life Insurance Underwriting As the country creeps back into reopening, life insurance companies have made it easier to apply for policies, with several major companies easing requirements for face to face applications and exams....
by Ed Hinerman | Apr 22, 2020 | Covid-19, life insurance, life insurance exam, no exam
First An Update On Covid 19 Impact On Life Insurance Since my last post, while life insurance companies are still taking applications and approving new policies, underwriters with some companies have put restrictions, or postpones, on some situational areas. Probably...
by Ed Hinerman | Mar 31, 2020 | Covid-19, life insurance, no exam
Life Insurance Companies Adjust To COVID-19 Reality The life insurance industry is adjusting quickly, not just in their daily commitment to their customers, but also to the COVID-19 distancing needs of those who want to buy life insurance. More companies each day are...
by Ed Hinerman | Mar 30, 2020 | Covid-19, life insurance
Where We Were Yesterday Yesterday I broke ground on several subjects that are on the minds of many about life insurance. I talked about the solid ground that life insurance companies are on financially and I talked about the challenges and solutions they, and you, are...
by Ed Hinerman | Mar 19, 2020 | Covid-19, life insurance
Are Life Insurance Companies Capable Of Handling A Pandemic? These are certainly crazy times and the truth is we don’t know how bad things will get or when this will resolve and life will begin to return to normal. I had a customer call a few days ago asking if...
by Ed Hinerman | Sep 13, 2018 | Covid-19, life insurance approval, prostate cancer, prostate cancer watchful waiting
I wrote the post below a few years ago and things have been changing, so here is an updated version of the information. The Way It’s Been I’ve written for years about the best underwriting and life insurance prices available for those with treated and...
Recent Comments